Targeted Radiotherapy for Neuroblastoma
Author Information
Author(s): R.J. Mairs, W. Angerson, M.N. Gaze, T. Murray, J.W. Babich, R. Reid, C. McSharry
Primary Institution: Department of Radiation Oncology, CRC Beatson Laboratories, Glasgow
Hypothesis
Which radiopharmaceutical vehicle is most effective for penetrating the center of neuroblastoma micrometastases?
Conclusion
mIBG is the most effective vehicle for targeted radiotherapy of neuroblastoma cells.
Supporting Evidence
- mIBG and PNGF penetrated the center of spheroids readily, while UJ13A was only bound peripherally.
- The concentration of mIBG greatly exceeded that of PNGF.
- Prolonged incubation with PNGF did not increase uptake levels beyond those seen at 2 hours.
Takeaway
This study looked at how well different drugs can get into tiny tumors called neuroblastoma spheroids. They found that one drug, mIBG, works best at getting inside these tumors.
Methodology
The study used human neuroblastoma spheroids to compare the penetration of three radiopharmaceuticals: mIBG, UJ13A, and PNGF.
Limitations
The study primarily focused on in vitro models, which may not fully represent in vivo conditions.
Want to read the original?
Access the complete publication on the publisher's website